Abstract:Background: The radiographic classification of pulmonary nodules into benign versus malignant categories is a pivotal component of early lung cancer diagnosis. The present study aimed to investigate clinical and computed tomography (CT) clinical-radiomics nomogram for preoperative differentiation of benign and malignant pulmonary nodules.Methods: This retrospective study included 342 patients with pulmonary nodules who underwent high-resolution CT (HRCT) examination. We assigned them to a training dataset (n=239) and a validation dataset (n=103). There are 1781 tumor characteristics quantified by extracted features from the lesion segmented from patients' CT images. The features with poor reproducibility and high redundancy were removed. Then a least absolute shrinkage and selection operator (LASSO) logistic regression model with 10-fold cross-validation was used to further select features and build radiomics signatures. The independent predictive factors were identified by multivariate logistic regression. A radiomics nomogram was developed to predict the malignant probability. The performance and clinical utility of the clinical-radiomics nomogram was evaluated by receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA).Results: After dimension reduction by the LASSO algorithm and multivariate logistic regression, four radiomic features were selected, including original_shape_Sphericity, exponential_glcm_Maximum Probability, log_sigma_2_0_mm_3D_glcm_Maximum Probability, and ogarithm_firstorder_90Percentile. Multivariate logistic regression showed that carcinoembryonic antigen (CEA) [odds ratio (OR) 95% confidence interval (CI): 1.40 (1.09-1.88)], CT rad score [OR (95% CI): 2.74 (2.03-3.85)], and cytokeratin-19-fragment (CYFRA21-1) [OR (95% CI): 1.80 (1.14-2.94)] were independent influencing factors of malignant pulmonary nodule (all P<0.05). The clinical-radiomics nomogram combining CEA, CYFRA21-1 and radiomics features achieved an area of curve (AUC) of 0.85 and 0.76 in the training group and verification group for the prediction of malignant pulmonary nodules. The clinical-radiomics nomogram demonstrated excellent agreement and practicality, as evidenced by the calibration curve and DCA.Conclusions: The clinical-radiomics nomogram combined of CT-based radiomics signature, along with CYFRA21-1 and CEA, demonstrated strong predictive ability, calibration, and clinical usefulness in distinguishing between benign and malignant pulmonary nodules. The use of CT-based radiomics has the potential to assist clinicians in making informed decisions prior to biopsy or surgery while avoiding unnecessary treatment for non-cancerous lesions.

Predictive factors for malignancy in incidental pulmonary nodules detected in breast cancer patients at baseline CT

Will That Pulmonary Nodule Become Cancerous? A Risk Prediction Model for Incident Lung Cancer

Clinical significance of noncalcified lung nodules in patients with breast cancer

Risk of Malignancy in Incidentally Detected Lung Nodules in Patients Aged Younger Than 35 Years

The Pulmonary Nodule "discovered" by Pneumonia: a Case Report.

The Utility of Nodule Volume in the Context of Malignancy Prediction for Small Pulmonary Nodules

Incidental Pulmonary Nodules: Differential Diagnosis and Clinical Management

Predictive Model for the Diagnosis of Benign/malignant Small Pulmonary Nodules

An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary Subsolid Nodules Based on Current and Prior CT Scans.

Evaluating the Patient With a Pulmonary Nodule: A Review

The pattern of lymph node metastasis in peripheral pulmonary nodules patients and risk prediction models

Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy

Using a risk model for probability of cancer in pulmonary nodules

The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules

Establishment and verification of a prediction model based on clinical characteristics and computed tomography radiomics parameters for distinguishing benign and malignant pulmonary nodules

[The pulmonary nodule: from incidental finding to pathological confirmation]

Outcomes of incidental pulmonary nodules detected in oral and oropharyngeal cancer patients

Management of incidental pulmonary nodules: current strategies and future perspectives

Benign‐malignant classification of pulmonary nodules by low‐dose spiral computerized tomography and clinical data with machine learning in opportunistic screening

[Establishment and Verification of A Novel Predictive Model of Malignancy for Non-solid Pulmonary Nodules]

Prediction Model for Lung Cancer in High-Risk Nodules Being Considered for Resection: Development and Validation in a Chinese Population